http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104127441-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate | 2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104127441-B |
titleOfInvention | Eye drops of anti-kopiopia and preparation method thereof |
abstract | A kind of eye drops of anti-kopiopia is made up of following composition:Ammonia iodine peptide eye drops, inosine injection, tribiofosfor injection, raceanisodamine injection, vitamin b6 injection, taurine eye drops and ophthalmically acceptable auxiliary agent, wherein ophthalmically acceptable auxiliary agent is following at least one:Water for injection or isotonic regulator, isotonic regulator are following at least one:Sodium chloride physiological saline, glucose injection, sorbierite eye drops, borate buffer solution, formula mannitol injection liquid or polyethylene glycol eye drops;The invention also discloses a kind of preparation method of the eye drops of anti-kopiopia;Advantage of the present invention has:One is that the overall efficacy of compound formulation is substantially better than unisexuality effect of drugs;Two be that the whole process of disease is played a role, and dose is reduced, side effect reduction;Three be the precondition that mutually synergy, effect are complementary to one another and had an effect each other between each medicine;Four be that drug effect is obvious, and it is convenient to be applicable, and is easy to carry. |
priorityDate | 2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.